A low-temperature adjustable myocardial diagnostic and therapeutic integrated cryoablation / dissection system
The cryoablation/excision system for myocardial diagnosis and treatment, which combines cryogenic freezing and excision techniques, solves the problems of sampling success rate and safety in myocardial biopsy and cryoablation, and achieves accurate sampling and safe ablation of myocardial tissue.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- FOURTH MILITARY MEDICAL UNIVERSITY
- Filing Date
- 2023-09-21
- Publication Date
- 2026-07-17
AI Technical Summary
Current myocardial biopsy methods suffer from poor sampling success rates, low diagnostic accuracy, and a tendency to cause irreversible conduction bundle damage. In particular, during cardiac cryoablation, the ablation range cannot be precisely controlled, leading to complications such as conduction block and malignant arrhythmias.
The system employs a low-temperature adjustable myocardial diagnostic and therapeutic cryoablation/dissection system, which combines low-temperature refrigerant gas freezing fixation with an adjustable dissection method. Through cryoablation needles, puncture needles, and a refrigerant device, it achieves precise sampling and safe ablation of myocardial tissue.
This method achieves high precision and safety in myocardial biopsy, reduces conduction bundle damage and complications, ensures the safety and precision of cryoablation, and avoids problems such as perforation and bleeding in traditional methods.
Smart Images

Figure CN117179880B_ABST